Kembali
Webinar Video
EBC Webinar with RS Mitra Keluarga – Core Biopsy Pros & Cons
Slide
EBC Webinar with RS Mitra Keluarga – Clinical Practice Guideline for Adjuvant Therapy in HER2+ eBC
Slide
Case Study 4: Rewriting the Patient Experience with Subcutaneous dual blockade
Watch
Case Study 3: The Impact of Dual Blockade on Reducing the risk of Recurrence in the Adjuvant Setting
Watch
Case Study 2: How can NAT help increase Breast-conserving surgery rates?
Watch
Case Study 1: Achieving better long-term Outcomes in HER2+ BC with NAT
Watch
Case Study 1. Making optimal treatment decisions for patients with high risk HER2-positive eBC
Watch
Clinical and Economic Value of Subcutaneous Dual Anti-HER2 Targeted Therapy
Watch
Post Neoadjuvant Treatment Surgery Intervention: BCS vs Mastectomy
Slide
Clinical Practice Guideline for Neoadjuvant Therapy in Early Breast Cancer
Slide
Pathology Workup for Early Breast Cancer Diagnosis and Evaluation Neoadjuvant Treatment
Slide
Optimal Early Breast Cancer Diagnosis & Management: A Collaborative approach
Slide
Safety of T-DM1 in HER2+ Advanced Breast Cancer Patients: Final result of Asia Cohort of KAMILLA Study & Experience Sharing
Watch
12th APBCS: What are your views on the possibilities of decentralized care for BC patients?
Watch
12th APBCS: How would you select patients for SC formulation of dual blockade?
Watch
12th APBCS: Benefits and practically of applying subcutaneous HER2-targeted antibodies in breast cancer treatment
Watch
Henry Cain: Providing response-directed systemic treatments
Watch
Henry Cain: Leveraging response to optimize breast surgery
Watch
Henry Cain: Why should surgeons consider NAC in early breast cancer
WatchM-ID-00001559-10-2024
